Transgene SA
OTC:TRGNF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Transgene SA
OTC:TRGNF
|
FR |
|
C
|
Chalice Mining Ltd
F:C8U
|
AU |
|
ARC Resources Ltd
TSX:ARX
|
CA |
|
E
|
Entegris Inc
F:ENQ
|
US |
|
A
|
ARC Resources Ltd
F:8RC
|
CA |
|
MainStreet Bancshares Inc
NASDAQ:MNSB
|
US |
|
OC Oerlikon Corporation AG Pfaeffikon
F:OBH0
|
CH |
|
JAFCO Group Co Ltd
TSE:8595
|
JP |
|
Wacker Neuson SE
OTC:WKRCF
|
DE |
|
OC Oerlikon Corporation AG Pfaeffikon
SIX:OERL
|
CH |
|
Danakali Ltd
ASX:DNK
|
AU |
|
Rayonier Advanced Materials Inc
NYSE:RYAM
|
US |
|
R
|
Rayonier Advanced Materials Inc
F:RYQ
|
US |
Bankruptcy Probability
Transgene SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Transgene SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Transgene SA
PAR:TNG
|
204m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
438.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
194.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
69.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Transgene SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Transgene SA has total debt of 1.7m EUR. This includes both short-term (0 EUR) and long-term (1.7m EUR) debt.
You can find a full breakdown on its Balance Sheet.
